2607.HK
2607.HK
CNE1000012B3
SH PHARMA
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
40.9B EUR
42.28B EUR
42.83B EUR
42.09B EUR
Enterprise Value
68.26B EUR
58.69B EUR
65.21B EUR
61.65B EUR
Valuation Multiples
Trailing P/E
7.66x
10.36x
8.36x
8.36x
Forward P/E
5.81x
--
--
--
Price to Sales
0.14x
0.2x
0.2x
0.2x
Price to Book
0.45x
0.54x
0.55x
0.55x
EV/Revenue
0.24x
0.27x
0.3x
0.29x
EV/EBITDA
6.23x
5.33x
5.07x
6.2x
Price to FCF (P/FCF)
32.15x
6.5x
10.22x
14.24x
EV/FCF
53.65x
9.03x
15.55x
20.86x
FCF Yield
3.11%
15.37%
9.79%
7.02%
ende